Fate Therapeutics Inc is a pioneering biopharmaceutical firm based in San Diego, California, focusing on the creation of innovative cellular immunotherapies for cancer and immune disorders. The company is at the forefront of developing treatments using natural killer (NK) and T-cells, targeting conditions like multiple myeloma, lymphoma, autoimmune disorders, hematologic malignancies, and solid tumors. Through a strategic partnership with Ono Pharmaceutical Co. Ltd., Fate Therapeutics is advancing the development of off-the-shelf, iPSC-derived CAR T-cell therapies, aiming to revolutionize cancer treatment.